Eli Lilly (LLY) Stock Jumps 16% in a Day: Here’s Why
15
3
Eli Lilly (LLY) stock climbed as much as 16% on Thursday after a study found that its weight loss pill works as well as Ozempic. The company expects to seek regulatory approvals by the end of the year, which led to a positive investor reaction. The pill met the company’s goals in a late-stage trial, helping Type 2 diabetes patients lower their blood sugar and body weight. The results exceeded expectations and were highly anticipated in the pharmaceutical industry.
By:
Previous
Chainlink LINK Powers CapMoney’s cUSD with Price Feeds Amid Market Challenges
Next
ChainGPT to Advance Web3 and AI Integration in Partnership with Marlin Protocol
